Can the placebo be the cure? Science 1999;284:238–240.
The use of placebos in psychiatry: a response to the draft document prepared by the Tri-Council Working Group. Canadian College of Neuropsychopharmacology.
J Psychiatry Neurosci 1996;21:235–238.
Indian study sparks debate on the use of placebo in psychiatry trials.
Benefits and burdens of placebos in psychiatric research.
Psychopharmacology (Berl) 2003;171:13–18.
5.Carpenter, WT Jr,
The rationale and ethics of medication-free research in schizophrenia.
Arch Gen Psychiatry 1997;54:401–407.
Greenhouse, Jet al. Cost utility analysis of maintenance treatment for recurrent depression.
Control Clin Trials 1995;16:17–40.
Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997;349:1498–1504.
Mcelroy, SLet al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
Arch Gen Psychiatry 2000;57:481–489.
The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective.
Eur Psychiatry 2001;16:418–423.
Placebo response in studies of major depression: variable, substantial, and growing.
The mousetrap: managing the placebo effect in antidepressant trials.
Mol Interv 2002;2:72–76.
Lithium use and discontinuation in a health maintenance organization.
Am J Psychiatry 1996;153:993–1000.
Arcona, Set al. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders.
Psychiatr Serv 2007;58:85–91.